The presence of PD-1 positive tumor infiltrating lymphocytes in triple negative breast cancers is associated with a favorable outcome of disease
Triple negative breast cancer patients have a poor course of disease not least because of limited treatment options however immunotherapy by targeting the PD-1/PD-L1 checkpoint system is a promising strategy to improve the outcome. Here we systematically investigated the expression of PD-1 on tumor...
Saved in:
Published in | Oncotarget Vol. 9; no. 5; pp. 6201 - 6212 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Impact Journals LLC
19.01.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!